A modern approach to glucose-lowering therapy in frail older people with type 2 diabetes mellitus

Expert Rev Endocrinol Metab. 2022 Mar;17(2):95-98. doi: 10.1080/17446651.2022.2044304. Epub 2022 Feb 25.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aged
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Frail Elderly
  • Glucose
  • Humans
  • Hypoglycemic Agents / therapeutic use

Substances

  • Hypoglycemic Agents
  • Glucose